To date, there have not been any reported robust small-animal models of human parainfluenza virus type 3 (HPIV-3) infection. Researchers from Katholieke Universiteit Leuven and affiliated organizations thus developed a novel inbred mouse HPIV-3 infection model for prophylactic and therapeutic modalities.